Inicio › Leucemia mielógena aguda › Florida › Tampa
Ensayos clínicos de Leucemia mielógena aguda en Tampa, FL
29 estudios para Leucemia mielógena aguda buscan participantes en centros de Tampa y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ReclutandoFase 2
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
ReclutandoFase 2/3
- Moffitt Cancer Center /ID# 279192, Tampa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
ReclutandoFase 1
- Moffitt Cancer Center, Tampa
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ReclutandoFase 3
- Moffit Cancer center, Tampa
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
ReclutandoFase 3
- Tampa General Hospital, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Study of BGB-11417 in Participants With Myeloid Malignancies
ReclutandoFase 1/2
- Tampa General Hospital, Tampa
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
ReclutandoFase 1
- Moffitt Cancer Center, Tampa
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
ReclutandoFase 1/2
- Moffitt Cancer Center and Research Institute Hospital, Tampa
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
ReclutandoFase 1/2
- Moffitt Cancer Center, Tampa
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
ReclutandoFase 1
- Moffitt Cancer Center, Tampa
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ReclutandoFase 1/2
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
ReclutandoFase 3
- Saint Joseph's Hospital - Tampa, Tampa
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
ReclutandoFase 3
- Moffitt Cancer Center & Research Institute, Tampa
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
ReclutandoFase 1
- H Lee Moffitt Cancer Center & Research Institute, Tampa
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
ReclutandoFase 3
- Moffitt Cancer Center, Tampa
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ReclutandoFase 2
- Moffitt Cancer Center, Tampa
BCL2i CLAG-M in R/R Acute Myeloid Leukemia
ReclutandoFase 2
- Moffitt Cancer Center, Tampa
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
ReclutandoFase 1/2
- Moffitt Cancer Center, Tampa
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
ReclutandoFase 1
- Moffitt Cancer Center, Tampa
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
ReclutandoFase 2
- Moffitt Cancer Center, Tampa
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
ReclutandoFase 2
- Moffitt Cancer Center, Tampa
CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
ReclutandoFase 1
- Moffitt Cancer Center, Tampa
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
ReclutandoFase 1
- Moffitt, Tampa
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ReclutandoFase 1
- Moffitt Cancer Center, Tampa
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
ReclutandoFase 1
- Moffitt Cancer Center, Tampa
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
ReclutandoFase 1
- Moffitt Cancer Center, Tampa
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
ReclutandoSe aceptan voluntarios sanos
- Moffitt Cancer Center, Tampa
Study of REM-422 in Patients With AML or Higher Risk MDS
ReclutandoFase 1
- Moffitt Cancer Center, Tampa
Más información sobre Leucemia mielógena aguda en MedlinePlus
Ensayos de Leucemia mielógena aguda en otras ciudades
- Houston, TX85 estudios
- New York City, NY51 estudios
- Boston, MA44 estudios
- Seattle, WA41 estudios
- Baldwin Park, CA40 estudios
- Columbus, OH35 estudios
- Philadelphia, PA34 estudios
- Durham, NC33 estudios
- Atlanta, GA31 estudios
- Chicago, IL26 estudios
- Portland, OR25 estudios
- Washington, DC24 estudios
Otros estudios en Tampa
- Cáncer de pulmón de células no pequeñas51 estudios
- Cáncer de seno43 estudios
- Cáncer (todos los tipos)39 estudios
- Cáncer del colon y del recto34 estudios
- Cáncer metastásico29 estudios
- Cáncer de pulmón29 estudios
- Cáncer de páncreas26 estudios
- Cáncer de ovario21 estudios
- Melanoma19 estudios
- Síndromes mielodisplásicos19 estudios
- Cáncer de próstata18 estudios
- Fallo cardíaco18 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.